⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6632566 | 0.83 | — | — | |
| SCHEMBL27901733 | 0.79 | TP53 (0.30) | — | |
| SCHEMBL28688857 | 0.75 | TP53 (0.37) | — | |
| SCHEMBL2213010 | 0.75 | SLC22A6 (0.32) | — | |
| SCHEMBL5798293 | 0.74 | — | — | |
| Ethylene SCHEMBL23700090 | 0.72 | HDAC1 (0.40) | — | |
| SCHEMBL4275032 | 0.72 | — | — | |
| SCHEMBL8346373 | 0.71 | PTGS1 (0.41) | — | |
| SCHEMBL28723280 | 0.71 | BLM (0.41) | — | |
| SCHEMBL2257854 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10759749-B2 | Therapeutic agent for diabetes | JCR PHARMACEUTICALS CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20190331700-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2019-10-31 | — | — | US | disclosed |
| EP-3508474-A1 | NOVEL THERAPEUTIC AGENT FOR DIABETES | JCR Pharmaceuticals Co., Ltd. (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190202781-A1 | NOVEL THERAPEUTIC AGENT FOR DIABETES | JCR PHARMACEUTICALS CO., LTD. (JP) | 2019-07-04 | — | — | US | disclosed |
| US-20180038878-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20160209434-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20140287444-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20140051102-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20130210044-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | SEKISUI MEDICAL CO., LTD. (JP) | 2013-08-15 | — | — | US | disclosed |
| US-20130164768-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | YAMAMOTO MITSUAKI (JP) | 2013-06-27 | — | — | US | disclosed |
| EP-1335026-B1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | DAIICHI PURE CHEMICALS CO LTD (JP) | 2007-09-19 | — | — | EP | disclosed |
| US-6979552-B2 | Method of lipid assay and reagent for use therein | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2005-12-27 | — | — | US | disclosed |
| US-20050142627-A1 | Method of lipid assay and reagent for use therein | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2005-06-30 | — | — | US | disclosed |
| US-20040231558-A1 | Has a clear hue, high light fastness and high moisture resistance | MITSUI CHEMICALS, INC. (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1441013-A1 | WATERCOLOR INK | Mitsui Chemicals, Inc. (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-20040053350-A1 | Method of lipid assay and reagent for use therein | SEKISUI MEDICAL CO., LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1335026-A1 | METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-5139930-A | Silver halide photographic light-sensitive material | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1992-08-18 | — | — | US | disclosed |
| EP-0159913-B1 | SILVER HALIDE PHOTOGRAPHIC LIGHT SENSITIVE MATERIAL | KONICA CORPORATION (JP) | 1988-09-14 | — | — | EP | disclosed |
| EP-0159913-A1 | Silver halide photographic light sensitive material | KONICA CORPORATION (JP) | 1985-10-30 | — | — | EP | disclosed |